Beta Bionics announced today that it began the U.S. launch of its iLet bionic pancreas with the Dexcom G7 continuous glucose monitor (CGM).
The launch marks the second G7-compatible automated insulin delivery system to hit the market in as many days. Yesterday, Tandem Diabetes Care became the first to launch an artificial pancreas using Dexcom’s next-generation CGM technology.
With a firmware update, users can update their iLet to integrate with the Dexcom G7 with no additional cost for new hardware.
To upgrade, users can download or update their iLet app on the Apple App Store or Google Play Store, available Dec. 18. Once updated, they can change the firmware on their iLet bionic pancreas and select their CGM. Other features help to streamline the setup process as well.
Get the full story at our sister site, Drug Delivery Business News.